Bette Caan to Clinical Trials Data Monitoring Committees
This is a "connection" page, showing publications Bette Caan has written about Clinical Trials Data Monitoring Committees.
Connection Strength
0.025
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17; 288(3):321-33.
Score: 0.025